EFMC
VNDA icon

Empire Financial Management Company’s Vanda Pharmaceuticals VNDA Stock Holding History

Empire Financial Management Company’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-922,245
Closed -$6.37M – 214
2026
Q1 		$6.37M Sell
922,245
-186,000
-17% -$1.43M 1.44% 14
2025
Q4 		$9.77M Buy
1,108,245
+350,154
+46% +$1.93M 2.12% 9
2025
Q3 		$3.78M Buy
758,091
+563,091
+289% +$2.61M 0.87% 34
2025
Q2 		$920K Buy
195,000
+45,000
+30% +$197K 0.27% 104
2025
Q1 		$689K Buy
150,000
+86,000
+134% +$401K 0.21% 117
2024
Q4 		$307K Buy
+64,000
New +$307K 0.1% 169
2024
Q2 		– Sell
-65,000
Closed -$267K – 218
2024
Q1 		$267K Buy
+65,000
New +$260K 0.09% 180

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Empire Financial Management Company's VNDA Position: Q2 2026 in Review

Empire Financial Management Company sold out of Vanda Pharmaceuticals (VNDA) in Q2 2026, closing a stake of 922,245 shares — an estimated $6.37M sold.

Empire Financial Management Company first reported a position in VNDA in Q1 2024 and held it in 7 quarters. The position peaked at $9.77M in Q4 2025. 173 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Empire Financial Management Company reported no remaining Vanda Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Empire Financial Management Company sold 922,245 Vanda Pharmaceuticals shares in Q2 2026, an estimated $6.37M.
  • Empire Financial Management Company first reported a position in Vanda Pharmaceuticals in Q1 2024 and held it in 7 quarters.
  • Empire Financial Management Company's Vanda Pharmaceuticals position peaked at $9.77M in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Empire Financial Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.